Plx pharma inc. (PLXP)
Balance Sheet / Yearly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13
CURRENT ASSETS
Cash and cash equivalents

9,286

14,001

18,509

21,256

24,318

14,250

16,537

17,924

20,418

24,404

30,438

25,079

-

59

-

-

-

-

-

-

-

-

-

-

-

-

Accounts receivable

2

18

-

193

15

18

41

127

76

19

56

381

-

5

-

-

-

-

-

-

-

-

-

-

-

-

Prepaid expenses and other current assets

248

263

250

266

307

421

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Inventory, net

-

-

-

-

-

-

0

0

0

246

372

394

-

116

-

-

-

-

-

-

-

-

-

-

-

-

Vendor and security deposits

-

-

-

-

-

-

86

575

1,168

719

247

657

-

0

-

-

-

-

-

-

-

-

-

-

-

-

Cash and Cash Equivalents

-

-

-

-

-

-

-

-

-

-

-

-

12,414

-

7,838

7,586

4,169

5,234

9,193

28,689

23,999

27,040

29,892

32,643

36,065

3,861

Interest Receivable

-

-

-

-

-

-

-

-

-

-

-

-

36

-

-

-

-

-

-

-

-

-

-

-

-

-

Short-term Investments

-

-

-

-

-

-

-

-

-

-

-

-

-

-

10,995

14,983

22,981

26,977

26,980

11,991

-

-

-

-

-

-

Prepaid expenses

-

-

-

-

-

-

470

584

268

300

336

359

83

4

169

207

107

146

154

229

133

120

133

165

216

46

Deferred financing costs

43

-

-

-

130

174

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Security deposit

-

-

-

-

-

-

4

4

4

-

4

4

-

4

-

-

-

-

-

-

-

-

-

-

-

-

TOTAL CURRENT ASSETS

9,581

14,283

18,759

21,716

24,772

14,865

17,139

19,217

21,935

25,689

31,455

26,876

12,533

189

19,004

22,777

27,259

32,358

36,328

40,910

24,132

27,160

30,025

32,808

36,282

3,907

NON-CURRENT ASSETS
Property and equipment, net

1,437

1,466

1,392

1,364

1,345

1,394

1,449

1,516

1,181

1,029

902

513

-

426

-

-

-

-

-

-

-

-

-

-

-

-

Right of use assets

548

618

699

574

644

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Intangible assets, net

-

-

-

-

-

-

-

-

-

-

2,296

2,300

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Goodwill

2,061

2,061

2,061

2,061

2,061

2,061

2,061

2,061

2,061

2,061

2,061

2,061

-

0

-

-

-

-

-

-

-

-

-

-

-

-

Security deposit

73

73

73

67

67

67

67

67

67

67

56

56

-

0

-

-

-

-

-

-

-

-

-

-

-

-

Note Receivable from advance to PLx Pharma, Inc.

-

-

-

-

-

-

-

-

-

-

-

-

2,000

-

-

-

-

-

-

-

-

-

-

-

-

-

Security Deposit

-

-

-

-

-

-

-

-

-

-

-

-

56

-

56

56

92

49

-

49

49

49

49

49

-

-

Security Deposit

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

49

-

-

-

-

-

-

-

Deferred Initial Public Offering costs

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

122

TOTAL OTHER ASSETS

-

-

-

-

-

-

-

-

-

-

-

-

2,056

-

56

56

92

49

49

49

49

49

49

49

-

122

TOTAL ASSETS

13,701

18,502

22,986

25,784

28,891

18,388

20,718

22,862

25,246

28,848

36,771

31,807

14,590

616

19,060

22,834

27,352

32,407

36,377

40,960

24,182

27,209

30,075

32,857

36,282

4,030

CURRENT LIABILITIES
Accounts payable and accrued liabilities

761

928

1,290

1,501

702

687

750

477

821

852

1,045

476

462

862

890

945

869

1,606

805

1,169

697

1,260

1,298

667

687

823

Accrued bonuses

317

1,166

907

711

473

1,048

755

504

307

849

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

Accrued interest

557

34

40

49

58

60

56

55

-

54

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Current portion of term loan, net of discount and fees

3,377

3,658

3,626

3,594

3,563

2,909

1,952

1,003

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Current lease liabilities

-

-

-

296

301

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Accrued severance

-

-

-

-

-

-

-

-

-

-

2,409

2,284

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Accrued interest

-

-

-

-

-

-

-

-

55

-

51

0

-

64

-

-

-

-

-

-

-

-

-

-

-

-

Accrued interest related parties

-

-

-

-

-

-

-

-

-

-

0

0

-

30

-

-

-

-

-

-

-

-

-

-

-

-

Convertible notes payable

-

-

-

-

-

-

-

-

-

-

0

0

-

1,297

-

-

-

-

-

-

-

-

-

-

-

-

Convertible notes payable related parties

-

-

-

-

-

-

-

-

-

-

0

0

-

480

-

-

-

-

-

-

-

-

-

-

-

-

Other current liabilities

319

304

309

-

-

26

26

60

59

59

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

TOTAL CURRENT LIABILITIES

5,334

6,093

6,173

6,154

5,099

4,732

3,540

2,101

1,245

1,815

3,505

2,760

-

2,735

-

-

-

-

-

-

-

-

-

-

-

-

NON-CURRENT LIABILITIES
Deferred revenue

-

-

-

-

-

-

-

-

-

-

200

200

-

200

-

-

-

-

-

-

-

-

-

-

-

-

Accrued interest, net of current portion

-

501

462

417

365

309

253

198

144

89

35

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

Term loan, net of discount, fees and current portion

-

622

1,548

2,467

3,377

4,280

5,175

6,061

7,003

6,942

6,868

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

Warrant liability

3,648

8,247

10,118

15,617

10,264

2,537

8,224

7,816

6,818

15,242

13,877

14,130

-

0

-

-

-

-

-

-

-

-

-

-

-

-

Accrued dividends

1,378

1,058

741

429

128

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other liabilities

321

409

488

377

449

84

124

130

136

141

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

Security deposit

-

-

-

-

-

-

-

-

-

-

68

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

TOTAL LIABILITIES

10,683

16,933

19,533

25,464

19,684

11,944

17,319

16,308

15,347

24,232

24,555

17,090

462

2,935

890

945

869

1,606

805

1,169

697

1,260

1,298

667

687

823

Commitments and contingencies

-

-

-

-

-

-

0

0

0

-

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

Series A convertible preferred stock: $0.001 par value; liquidation value of $16,378,788 and $16,058,498, respectively; 45,000 shares designated, 15,000 shares issued and outstanding

13,661

13,661

13,661

13,661

13,661

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

STOCKHOLDERS' EQUITY (DEFICIT)
Preferred stock; $0.001 par value; 955,000 shares authorized; none issued and outstanding

-

-

-

-

-

-

0

0

0

-

0

0

-

0

-

-

-

-

-

-

-

-

-

-

-

-

Members' Equity

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

0

3,206

Common stock; $0.001 par value; 100,000,000 shares authorized; 9,156,260 shares issued and outstanding

9

9

9

8

8

8

8

8

8

8

8

8

11

4

10

10

10

10

10

10

8

8

8

8

8

-

Additional paid-in capital

74,789

74,837

74,720

73,291

72,831

72,871

72,772

72,502

72,243

71,939

71,655

70,357

78,029

49,661

75,077

74,164

73,350

71,852

71,119

70,318

49,981

48,259

47,812

47,383

46,867

-

Accumulated deficit

-85,442

-86,938

-84,938

-86,641

-77,294

-66,435

-69,382

-65,957

-62,353

-67,332

-59,448

-55,648

-63,912

-51,985

-56,917

-52,286

-46,878

-41,061

-35,557

-30,537

-26,505

-22,318

-19,044

-15,201

-11,281

-

TOTAL STOCKHOLDERS' EQUITY (DEFICIT)

-10,643

-12,091

-10,208

-13,341

-4,453

6,444

3,399

6,554

9,898

4,616

12,216

14,717

14,128

-2,319

18,170

21,888

26,483

30,801

35,572

39,790

-

25,949

-

-

-

-

TOTAL SHAREHOLDERS' EQUITY

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

23,484

-

28,776

32,190

35,594

3,206

TOTAL LIABILITIES, SERIES A CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' EQUITY (DEFICIT)

13,701

18,502

22,986

25,784

28,891

18,388

20,718

22,862

25,246

28,848

36,771

31,807

14,590

616

19,060

22,834

27,352

32,407

36,377

40,960

24,182

27,209

30,075

32,857

36,282

4,030